SOLICITATION NOTICE
A -- Midazolam Autoinjectors Project Bioshield
- Notice Date
- 7/2/2021 1:28:24 PM
- Notice Type
- Solicitation
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ Washington DC 20515 USA
- ZIP Code
- 20515
- Solicitation Number
- 75A50121R00003
- Response Due
- 7/30/2021 1:00:00 PM
- Archive Date
- 08/14/2021
- Point of Contact
- Jill Johnson, Contracting Officer, Phone: 202-816-1148, Kevin Restrepo, Contract Specialist, Phone: 202-815-2367
- E-Mail Address
-
jill.johnson@hhs.gov, kevin.restrepo@hhs.gov
(jill.johnson@hhs.gov, kevin.restrepo@hhs.gov)
- Description
- This Request for Proposal (RFP) covers the advanced research and development, procurement, and delivery of adult and pediatric midazolam autoinjectors that have received FDA approval for the treatment of status epilepticus seizures (including seizures caused by nerve agents) in adult and pediatric populations (2+ years of age). Please see attached RFP for additional details.�
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/24e6350e461c4e27b1d399a45288e946/view)
- Record
- SN06050369-F 20210704/210702230110 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |